Open access peer-reviewed chapter

Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?

By John King-Underwood, Steven M. Allin, Charles W. Redman and Alan Richardson

Submitted: February 17th 2011Reviewed: July 16th 2011Published: February 17th 2012

DOI: 10.5772/27377

Downloaded: 2763

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

John King-Underwood, Steven M. Allin, Charles W. Redman and Alan Richardson (February 17th 2012). Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?, Ovarian Cancer Samir A. Farghaly, IntechOpen, DOI: 10.5772/27377. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/ovarian-cancer-basic-science-perspective/autotaxin-a-target-for-the-treatment-of-drug-resistant-ovarian-cancer-" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2763total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer

By Gregory Lee, Mingang Zhu and Bixia Ge

Related Book

First chapter

Ovarian Cancer Incidence: Current and Comprehensive Statistics

By Sherri L. Stewart

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us